BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38612962)

  • 21. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
    Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
    Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
    Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
    BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study.
    Engel LS; Satagopan J; Sima CS; Orlow I; Mujumdar U; Coble J; Roy P; Yoo S; Sandler DP; Alavanja MC
    Environ Health Perspect; 2014 Feb; 122(2):165-71. PubMed ID: 24252436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
    Kensler KH; Regan MM; Heng YJ; Baker GM; Pyle ME; Schnitt SJ; Hazra A; Kammler R; Thürlimann B; Colleoni M; Viale G; Brown M; Tamimi RM
    Breast Cancer Res; 2019 Feb; 21(1):30. PubMed ID: 30795773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
    Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
    PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort.
    Aristarco V; Johansson H; Gandini S; Macis D; Zanzottera C; Tolva G; Feroce I; Accornero C; Bonanni B; Guerrieri-Gonzaga A; Serrano D
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.
    Iqbal Mu; Khan TA; Maqbool SA
    PLoS One; 2015; 10(3):e0122657. PubMed ID: 25799416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
    Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
    Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis.
    Perna L; Butterbach K; Haug U; Schöttker B; Müller H; Arndt V; Holleczek B; Burwinkel B; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):437-42. PubMed ID: 23300018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
    Lundgren C; Bendahl PO; Ekholm M; Fernö M; Forsare C; Krüger U; Nordenskjöld B; Stål O; Rydén L
    Breast Cancer Res; 2020 Dec; 22(1):140. PubMed ID: 33357231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of vitamin D receptor in digestive system tumours: A systematic review and preliminary meta-analysis.
    Zhao M; Liu Z; Shi H; Song J
    PLoS One; 2023; 18(8):e0289598. PubMed ID: 37561808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of Vitamin D Receptor (VDR) Expression Profile in Normal and Malignant Breast Tissues.
    Zhalehjoo N; Shakiba Y; Panjehpour M
    Clin Lab; 2016 Aug; 62(8):1461-1468. PubMed ID: 28164608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.
    Abbas S; Nieters A; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res; 2008; 10(2):R31. PubMed ID: 18419802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D receptor expression in patients with vulvar cancer.
    Salehin D; Haugk C; Thill M; Cordes T; William M; Hemmerlein B; Friedrich M
    Anticancer Res; 2012 Jan; 32(1):283-9. PubMed ID: 22213317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation-related vitamin D receptor insensitivity in breast cancer.
    Marik R; Fackler M; Gabrielson E; Zeiger MA; Sukumar S; Stearns V; Umbricht CB
    Cancer Biol Ther; 2010 Jul; 10(1):44-53. PubMed ID: 20431345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
    Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
    JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.
    Jóźwicki W; Brożyna AA; Siekiera J; Slominski AT
    Int J Mol Sci; 2015 Oct; 16(10):24369-86. PubMed ID: 26501255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.